PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model

被引：0
|
作者：
Yuan Li
Yang Du
Ting Sun
Huadan Xue
Zhengyu Jin
Jie Tian
机构：
[1] Chinese Academy of Medical Sciences & Peking Union Medical College,Department of Radiology, Peking Union Medical College Hospital
[2] Chinese Academy of Sciences,Key laboratory of Molecular Imaging of CAS, The State Key Laboratory of Management and Control for Complex Systems, Institute of Automation
来源：
BMC Cancer | / 18卷
关键词：
PD-1; Zoledronic acid; Breast cancer; Therapy; Checkpoint inhibitior;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model
    Li, Yuan
    Du, Yang
    Sun, Ting
    Xue, Huadan
    Jin, Zhengyu
    Tian, Jie
    [J]. BMC CANCER, 2018, 18
  • [2] PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model
    Li, Yuan
    Du, Yang
    Sun, Ting
    Xue, Huadan
    Tian, Jie
    Jin, Zhengyu
    [J]. CANCER RESEARCH, 2017, 77
  • [3] COMBINATION OF VEGF-A AND PD-1 BLOCKADE MAY ENHANCE ANTITUMOR EFFICACY IN GBM
    Long, Yu
    Yang, Changlin
    Jin, Linchun
    Ge, Haitao
    Bao, Hongbo
    Flores, Catherine
    Lin, Zhiguo
    Mitchell, Duane
    Huang, Jianping
    [J]. NEURO-ONCOLOGY, 2016, 18 : 91 - 91
  • [4] The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer
    Xu, Naijin
    Huang, Linglong
    Li, Xiezhao
    Watanabela, Masami
    Li, Chaoming
    Xu, Abai
    Liu, Chunxiao
    Li, Qiang
    Araki, Motoo
    Wada, Koichiro
    Nasu, Yasutomo
    Huang, Peng
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (05): : 919 - 928
  • [5] PD-1 Blockade Enhances the Efficacy of Chemoradiation in a Mouse Model of Esophageal Cancer
    Oh, P.
    Du, K. L.
    Leichman, L.
    Aifantis, I.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S127 - S128
  • [6] Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a Mouse Model of Subcutaneous Tumor
    Shindo, Yoshitaro
    Yoshimura, Kiyoshi
    Kuramasu, Atsuo
    Watanabe, Yusaku
    Ito, Hideaki
    Kondo, Tomoko
    Oga, Atsunori
    Ito, Hiroshi
    Yoshino, Shigefumi
    Hazama, Shoichi
    Tamada, Koji
    Yagita, Hideo
    Oka, Masaaki
    [J]. ANTICANCER RESEARCH, 2015, 35 (01) : 129 - 136
  • [7] Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer
    Peng, Hui
    Li, Lijin
    Zuo, Chong
    Chen, Michael Y.
    Zhang, Xiuli
    Myers, Nancy B.
    Hogg, Graham D.
    DeNardo, David G.
    Goedegebuure, S. Peter
    Hawkins, William G.
    Gillanders, William E.
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer
    Ottewell, Penelope D.
    Monkkonen, Hannu
    Jones, Mark
    Lefley, Diane V.
    Coleman, Robert E.
    Holen, Ingunn
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (16) : 1167 - 1178
  • [9] A Combination of PD-1 and TIGIT Checkpoint Blockade Elicits a Strong Antitumor Response in the Patient and Mouse Pleural Mesothelioma Model
    Shi, H.
    Johnson, B.
    Yu, T. -K.
    Zhuang, L.
    Selvamani, S. P.
    Lee, K.
    Klebe, S.
    Chen, K.
    Clark, G.
    Kao, S.
    Silveira, P.
    Cheng, Y. Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S388 - S388
  • [10] Targeting metabolic vulnerabilities of MDSCs to enhance the antitumor activity of PD-1 blockade
    Kim, Sun Hye
    Li, Man
    Trousil, Sebastian
    Zheng, Bin
    [J]. CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
12345